ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko03440	Homologous recombination	17/175	41/7206	1.48683304593e-17
ko03460	Fanconi anemia pathway	17/175	51/7206	1.17423868692e-15
ko04110	Cell cycle	24/175	145/7206	4.71981456997e-14
ko04111	Cell cycle - yeast	15/175	90/7206	3.10125577304e-09
ko03410	Base excision repair	10/175	38/7206	1.44894247937e-08
ko04218	Cellular senescence	17/175	177/7206	1.16439509366e-06
ko03030	DNA replication	7/175	38/7206	2.95218803654e-05
ko04115	p53 signaling pathway	9/175	74/7206	6.80391028311e-05
ko03040	Spliceosome	12/175	145/7206	0.000196851031347
ko04113	Meiosis - yeast	8/175	70/7206	0.000269521420436
ko04914	Progesterone-mediated oocyte maturation	9/175	104/7206	0.000907056362871
ko03430	Mismatch repair	4/175	22/7206	0.00174566524364
ko04114	Oocyte meiosis	10/175	139/7206	0.00197164906577
ko03013	RNA transport	11/175	166/7206	0.0022907519258
ko05166	HTLV-I infection	16/175	292/7206	0.00254276497072
ko05203	Viral carcinogenesis	15/175	277/7206	0.00388468379312
ko05212	Pancreatic cancer	7/175	83/7206	0.003885999476
ko03420	Nucleotide excision repair	5/175	46/7206	0.00488604570061
ko00240	Pyrimidine metabolism	8/175	110/7206	0.00514783195631
ko05222	Small cell lung cancer	7/175	89/7206	0.00571307160002
ko03008	Ribosome biogenesis in eukaryotes	6/175	79/7206	0.0121139077888
ko05215	Prostate cancer	7/175	111/7206	0.0181001315238
ko05223	Non-small cell lung cancer	5/175	66/7206	0.0216382556268
ko05219	Bladder cancer	4/175	48/7206	0.0285310585776
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	3/175	28/7206	0.0295524294346
ko05161	Hepatitis B	9/175	173/7206	0.0382251007456
ko04370	VEGF signaling pathway	5/175	77/7206	0.0387537877481
ko05206	MicroRNAs in cancer	9/175	177/7206	0.0403381057006